Abstract

Abstract Early Growth Response 1 (EGR1) is a zinc finger transcription factor that is transiently up-regulated in T and B lymphocytes in response to mitogenic stimuli. It activates transcription of target genes required for cell division and differentiation. In T cells, EGR1 is known to integrate TCR signaling pathways with signaling cascades resulting from co-stimulation and cytokine ligation. In this study, we developed and characterized a novel monoclonal antibody for human EGR1 that can be used for intracellular (nuclear) staining and flow cytometric analysis. Using this antibody we have analyzed stimulatory requirements for the expression of this transcriptional regulator in human peripheral blood T cells.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.